title: Potential roles of other FK 506-binding proteins in mediating the effects of FK 506.
authors.affiliation: Department of Immunology Research, Merck, Sharp & Dohme Research Laboratories, Rahway, NJ 07065.
authors.forename: J J
authors.initials: JJ
authors.lastname: Siekierka
authors.forename: G
authors.initials: G
authors.lastname: Wiederrecht
authors.forename: J
authors.initials: J
authors.lastname: Cryan
authors.forename: S H
authors.initials: SH
authors.lastname: Hung
authors.forename: M
authors.initials: M
authors.lastname: Comisky
authors.forename: N H
authors.initials: NH
authors.lastname: Sigal
mesh_terms: D000591:Amino Acid Isomerases / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism / Q000502:physiology*; D002460:Cell Line; D016572:Cyclosporine / Q000378:metabolism; D006801:Humans; D007165:Immunosuppression Therapy; D019696:Peptidylprolyl Isomerase; D013601:T-Lymphocytes; D016559:Tacrolimus / Q000378:metabolism / Q000494:pharmacology*; D022021:Tacrolimus Binding Proteins
chemical_list: D002352:Carrier Proteins; D016572:Cyclosporine; D000591:Amino Acid Isomerases; D022021:Tacrolimus Binding Proteins; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus